Ann Chen Wu MD, MPH is an Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute and the Director of the PRecisiOn Medicine Translational Research (PROMoTeR) Center. She is a pediatrician and health services researcher, and is a member of the Center for Healthcare Research in Pediatrics (CHeRP). Dr. Wu is also leading the Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT) study; this research will link genetic variants to therapeutic responses with additional information from genomics and metabolomics to provide insight into the biologic pathways that may be activated in an age-dependent method. This study will elucidate response to the two most commonly used medications for asthma, inhaled steroids and β2-agonists. Her research interests are in health disparities, asthma, and pharmacogenetics.
After receiving her BS in Biology from the Massachusetts Institute of Technology and her MD from Harvard Medical School, Dr. Wu completed her pediatrics residency at Children's Hospital, Boston. She then spent two years in private practice in CT and completed a general pediatrics fellowship at Yale University School of Medicine. Prior to starting her faculty position at Department of Population Medicine, she was a Harvard Pediatric Health Services Fellow in the department and obtained an MPH from the Harvard School of Public Health. She practices general pediatrics at Children's Hospital Boston.
Dr. Wu is the lead investigator of the Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT) and co-lead on Genomics-based Technologies: Access and Reimbursement Issues.
Assistant in Medicine, Department of Medicine, Division of General Pediatrics, Children’s Hospital, Boston, MA